Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pappas

Showing results (231-240 of 235) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 235 results.
Science Translational Medicine|January 10, 2024
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virusFrancesco Andreata, Kelly D Moynihan, Valeria Fumagalli, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 29, 2001
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxisR H Rubin, S A Kemmerly, D Conti, et al.
International Journal of Cardiology|November 29, 2012
Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome--results from the countrywide TARGET studyG Andrikopoulos, S Tzeis, N Nikas, et al.
Cancer Discovery|April 2, 2024
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor ImmunityKelly D Moynihan, Manu P Kumar, Hussein Sultan, et al.
Cancer Immunology Research|August 11, 2021
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor ImmunityYuanming Xu, Lucia Campos Carrascosa, Yik Andy Yeung, et al.
Pageof 24

Showing results (231-240 of 235) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 235 results.
Science Translational Medicine|January 10, 2024
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virusFrancesco Andreata, Kelly D Moynihan, Valeria Fumagalli, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 29, 2001
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxisR H Rubin, S A Kemmerly, D Conti, et al.
International Journal of Cardiology|November 29, 2012
Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome--results from the countrywide TARGET studyG Andrikopoulos, S Tzeis, N Nikas, et al.
Cancer Discovery|April 2, 2024
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor ImmunityKelly D Moynihan, Manu P Kumar, Hussein Sultan, et al.
Cancer Immunology Research|August 11, 2021
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor ImmunityYuanming Xu, Lucia Campos Carrascosa, Yik Andy Yeung, et al.
Pageof 24